All News


Tale of two biotech stars

The CEOs of Ablynx and uniQure, at a Science|Business event, tell their growth stories – and what Europe needs to do if there are to be more companies like theirs bringing new medicines to market

Back small companies to deliver new medicines

Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection